Human Cell-Based in vitro Phenotypic Profiling for Drug Safety-Related Attrition
Ensuring the safety of new drugs is critically important to regulators, pharmaceutical researchers and patients alike. Even so, unexpected toxicities still account for 20–30% of clinical trial failures, in part due to the persistence of animal testing as the primary approach for de-risking new drugs...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2019-12-01
|
| Series: | Frontiers in Big Data |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/article/10.3389/fdata.2019.00047/full |